Quite the opposite for Elite actually. The longer we wait before we sign a partnership deal, the better off Elite is. JT even talked about this a few years ago. Makes no sense to do a deal until we get what WE want. We have the cash to put at least 2 products through all trials. So if big pharma wants a piece, you better believe Nasrat is going to make them pay up. $$$
And quoting from Nasrat, "A decision on a partner will be made before we file in December."